Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis.
about
Thiopurine drugs azathioprine and 6-mercaptopurine inhibit Mycobacterium paratuberculosis growth in vitroStructome analysis of virulent Mycobacterium tuberculosis, which survives with only 700 ribosomes per 0.1 fl of cytoplasmA systematic follow-up of Mycobacterium tuberculosis drug-resistance and associated genotypic lineages in the French Departments of the Americas over a seventeen-year periodDiscordance across several methods for drug susceptibility testing of drug-resistant Mycobacterium tuberculosis isolates in a single laboratory.Real-time PCR using mycobacteriophage DNA for rapid phenotypic drug susceptibility results for Mycobacterium tuberculosis.Rapid first- and second-line drug susceptibility assay for Mycobacterium tuberculosis isolates by use of quantitative PCR.Isothermal RNA sequence amplification method for rapid antituberculosis drug susceptibility testing of Mycobacterium tuberculosis.Characterization of the genetic diversity of Mycobacterium tuberculosis in São Paulo city, Brazil.Tuberculosis in the developing world: recent advances in diagnosis with special consideration of extensively drug-resistant tuberculosis.Evaluation of BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to first-line drugs in China.Evaluation of MGIT 960-based antimicrobial testing and determination of critical concentrations of first- and second-line antimicrobial drugs with drug-resistant clinical strains of Mycobacterium tuberculosis.The manual mycobacteria growth indicator tube and the nitrate reductase assay for the rapid detection of rifampicin resistance of M. Tuberculosis in low resource settings.Comparison between the BACTEC MGIT 960 system and the agar proportion method for susceptibility testing of multidrug resistant tuberculosis strains in a high burden setting of South AfricaComparison of Mycobacterium tuberculosis drug susceptibility using solid and liquid culture in NigeriaDirect drug susceptibility testing of Mycobacterium tuberculosis for rapid detection of multidrug resistance using the Bactec MGIT 960 system: a multicenter studyEvaluation of Xpert® MTB/RIF and Ustar EasyNAT™ TB IAD for diagnosis of tuberculous lymphadenitis of children in Tanzania: a prospective descriptive study.The emerging threat of pre-extensively drug-resistant tuberculosis in West Africa: preparing for large-scale tuberculosis research and drug resistance surveillanceMatrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Combined Species Identification and Drug Sensitivity Testing in Mycobacteria.Current perspectives on drug susceptibility testing of Mycobacterium tuberculosis complex: the automated nonradiometric systems.Evaluation of the fully automated BACTEC MGIT 960 system for testing susceptibility of Mycobacterium tuberculosis to pyrazinamide, streptomycin, isoniazid, rifampin, and ethambutol and comparison with the radiometric BACTEC 460TB method.The interval between initiation of anti-tuberculosis treatment in patients with culture-positive pulmonary tuberculosis and receipt of drug-susceptibility test resultsRapid Detection of Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Using Real-Time PCR.Reversion of antibiotic resistance in Mycobacterium tuberculosis by spiroisoxazoline SMARt-420.Rapid detection of Mycobacterium tuberculosis resistance to second-line drugs by use of the manual mycobacterium growth indicator tube system.Rapid identification and detection of intracellular survival testing of mycobacterium smegmatis mc²155 that contains eis gene from mycobacterium tuberculosis by flow cytometry.Susceptibility testing with the manual mycobacteria growth indicator tube (MGIT) and the MGIT 960 system provides rapid and reliable verification of multidrug-resistant tuberculosis.Drug-susceptibility testing in TB: current status and future prospects.Resistance to first-line tuberculosis drugs in three cities of Nigeria.Evaluation of the VersaTREK system compared to the Bactec MGIT 960 system for first-line drug susceptibility testing of Mycobacterium tuberculosis."In vitro" activities of antimycobacterial agents against Mycobacterium avium subsp. paratuberculosis linked to Crohn's disease and paratuberculosis.Whole-genome sequencing illuminates the evolution and spread of multidrug-resistant tuberculosis in Southwest Nigeria.Patients with pulmonary tuberculosis develop a strong humoral response against methylated heparin-binding hemagglutininMulticenter laboratory evaluation of the MB/BacT Mycobacterium detection system and the BACTEC MGIT 960 system in comparison with the BACTEC 460TB system for susceptibility testing of Mycobacterium tuberculosis.Molecular and Growth-Based Drug Susceptibility Testing of Mycobacterium tuberculosis Complex for Ethambutol Resistance in the United StatesReliability of Mycobacterial Growth Indicator Tube (MGIT) 960 for the detection of isoniazid resistance in a tuberculosis endemic setting.Performance assessment of the GenoType MTBDRplus test and DNA sequencing in detection of multidrug-resistant Mycobacterium tuberculosis.Prognostic Models for 9-Month Mortality in Tuberculous Meningitis.A randomised double blind placebo controlled phase 2 trial of adjunctive aspirin for tuberculous meningitis in HIV-uninfected adults.A cross-sectional study of tuberculosis drug resistance among previously treated patients in a tertiary hospital in Accra, Ghana: public health implications of standardized regimens.Evaluation of efficiency of nested multiplex allele-specific PCR assay for detection of multidrug resistant tuberculosis directly from sputum samples.
P2860
Q24656698-95A7ADCA-A9CF-4059-82C2-EF9E953A46B5Q28543142-9ACCB796-3991-484F-91FF-3FEF77A498F5Q29353709-7B0988CB-941C-46D6-9C9D-644F4DB4D73DQ30414792-0B89645B-E793-4024-BF1A-60F589A2DEBAQ30425212-14E680DF-C151-4F5C-90DE-FA7EA3176F89Q30431597-BB8AFF27-D7CD-4101-B000-DDDFC2AB422EQ33859255-79CD1589-B911-48DE-B3B1-08072C515573Q33975514-41BD8B3D-2C33-469C-BFFE-D35C3E7139A6Q34201423-3D93EB9E-2709-4F57-8FE7-49644D97B120Q34231472-818B713D-C11F-4332-848E-D4C82F155812Q34431677-6E86FD7D-F28F-4F4C-8288-4EBD5BBD4F38Q34491706-B3355201-9914-481A-97D2-9DA2AEE0E1F5Q34520274-1C71446D-88D7-40B0-BA8C-039C54117D8EQ34747768-4A735F54-A6E5-4C97-9D0B-6FAEF72EEC37Q35688986-89021590-FB02-409E-B578-EF54C7C07195Q36042802-7FF425C6-C8A6-49E5-A995-38FA4D0AC2C2Q36180685-5685FBD4-9507-4C99-A564-0E8C9157D5E5Q36230810-22DDD4AA-8850-46CA-AE34-CF42AA8A9098Q36359595-7CF896AB-81BF-4BFF-B342-1B686211CAADQ36600112-75AE4212-F268-45D3-AAFE-CC54628ED68CQ37220243-30C00CF4-DABC-40AE-ADFD-367AA23E22BFQ37471030-73E6CEF5-3BEC-439C-AACB-92E86227A37BQ38912109-83A11110-6290-40E3-B601-E0B10C4EB225Q39218265-7C69B34F-15DF-4D04-BB56-FBBFF7925222Q39486521-D137D752-1E8A-4B29-9118-948A29278E67Q39735527-9CCFA497-952C-4932-B29C-A8D86BFFFC6AQ39872573-3E8EA0B8-BEB4-4BEF-B241-ECBD6F9F8EE1Q39982841-E705300B-64F2-47BF-B960-BFDC7531FDC8Q40599116-47C20AEF-C7DA-45F5-ABEC-F23D9B2AC59AQ41503375-B88CD78F-37C3-4A90-B5F8-D316B087CC33Q41677504-0F7E9FE9-115C-496F-948D-DB4DF08FA950Q41886736-C4193FA6-10CD-4781-B93A-C8B86BF6A97CQ42432121-F6525DF9-5A53-46CB-9E1B-CF06243ECBCEQ42577091-14E15E37-B9A0-44DF-8F71-4FA6563D9160Q42708214-DBC13FBA-9C8D-4693-895A-49BA5AA519EEQ43071786-87E5C8C2-B0F6-42F0-8D6E-D88CBA7571BDQ50065137-7588377D-A219-41E7-A3DA-66C7416A6DB0Q51747428-55DFCCE7-D43C-44FD-B9A0-ED5668C785D3Q53696987-CBDED38D-DF06-405C-BFBA-F6C936F1E007Q53793398-03CF37C9-18FA-43FA-A9DD-1350466023D2
P2860
Evaluation of BACTEC Mycobacteria Growth Indicator Tube (MGIT 960) automated system for drug susceptibility testing of Mycobacterium tuberculosis.
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Evaluation of BACTEC Mycobacte ...... of Mycobacterium tuberculosis.
@ast
Evaluation of BACTEC Mycobacte ...... of Mycobacterium tuberculosis.
@en
type
label
Evaluation of BACTEC Mycobacte ...... of Mycobacterium tuberculosis.
@ast
Evaluation of BACTEC Mycobacte ...... of Mycobacterium tuberculosis.
@en
prefLabel
Evaluation of BACTEC Mycobacte ...... of Mycobacterium tuberculosis.
@ast
Evaluation of BACTEC Mycobacte ...... of Mycobacterium tuberculosis.
@en
P2093
P2860
P1476
Evaluation of BACTEC Mycobacte ...... of Mycobacterium tuberculosis.
@en
P2093
P2860
P304
P356
10.1128/JCM.39.12.4440-4444.2001
P407
P577
2001-12-01T00:00:00Z